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INTRODUCTION
Ceramides are the main lipids in the stratum corneum, and
their depletion is thought to be one of the etiological factors
for barrier disruption in various levels of skin conditions (1-
4). Marked depletion of ceramides in the stratum corneum
has been reported especially in patients with psoriasis and
atopic dermatitis.
Ceramides are generated by serine palmitoyltransferase
(SPT), the enzyme for de novo synthesis or by the action of
sphingomyelinase. As lipid second messengers, they mediate
antiproliferative and apoptotic effect via activation of several
signal transduction molecules such as protein kinase C-alpha
(PKC- ) and c-jun N-terminal kinase (JNK) (5-7). In our
previous study, the decreased levels of ceramide in psoriatic
skin lesions were shown to be responsible for epidermal hyper-
plasa via downregulation of proapoptotic signal cascade such
as PKC- and JNK. In contrast, diacyglycerol (DAG) levels
were elevated and free fatty acid levels were not changed (8,
9). However, in the past study, the ceramide level and pro-
tein expression of ceramide-metabolizing enzymes in psori-
atic skin lesion was not elucidated. In the present study mea-
sured the expression of SPT, key enzyme for de novo ceramide
synthesis, and ceramidase, the degradative enzyme of ceramide,
in both psoriatic epidermis and non-lesional epidermis.
MATERIALS AND METHODS
Patients and skin biopsies
Twenty four Korean patients with psoriasis (9 women, 15
men) ranging in age from 9 to 37 yr gave informed consent
and took part in this study. All the subjects had psoriasis
vulgaris as identified through clinical and histological assess-
ment and had not been treated either systemically or topi-
cally for at least 1 month before punch biopsies were done
(Table 1). Using a 4-mm punch, biopsies were taken from
lesional and non-lesional skin on the lower extremities, back,
or arms. The epidermis was separated as described previous-
ly (10). Specifically, the epidermis was separated from whole-
skin biopsies by overnight incubation at 4℃ in a 1:1 (v/v)
mixture of dispase solution (Roche Molecular Biochemicals,
Manheim, Germany) and Hank’s balanced salt solution (HB-
SS; Gibco BRL, Life Technologies, Rockville, MD, U.S.A.).
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A Study on Altered Expression of Serine Palmitoyltransferase and
Ceramidase in Psoriatic Skin Lesion
Ceramides are the main lipid component maintaining the lamellae structure of stra-
tum corneum, as well as lipid second messengers for the regulation of cellular prolif-
eration and/or apoptosis. In our previous study, psoriatic skin lesions showed mark-
ed decreased levels of ceramides and signaling molecules, specially protein kinase
C-alpha (PKC- ) and c-jun N-terminal kinase (JNK) in proportion to the psoriasis
area and severity index (PASI) scores, which suggested that the depletion of cera-
mide is responsible for epidermal hyperproliferation of psoriasis via downregulation
of proapoptotic signal cascade such as PKC- and JNK. In this study, we investigated
the protein expression of serine palmitoyltransferase (SPT) and ceramidase, two
major ceramide metabolizing enzymes, in both psoriatic epidermis and non-lesion-
al epidermis. The expression of SPT, the ceramide generating enzyme in the de novo
synthesis in psoriatic epidermis, was significantly less than that of the non-lesional
epidermis, which was inversely correlated with PASI score. However, the expres-
sion of ceramidase, the degradative enzyme of ceramides, showed no significant
difference between the lesional epidermis and the non-lesional epidermis of psori-
atic patients. This might suggest that decreased expression of SPT protein is one
of the important causative factors for decreased ceramide levels in psoriasis. 
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Assessing the clinical severity of psoriasis
The clinical severity was assessed using the psoriasis area
and severity index (PASI) score, which is calculated as follows:
PASI=0.1 (Eh+Ih+Dh)Ah+0.2 (Eu+Iu+Du)Au+0.3 (Et+It+
Dt)At+0.4 (El+Il+Dl)Al, where E=erythema, I=infiltration,
D=desquamation, A=area, h=head, u=upper extremities,
t=trunk, and l=lower extremities. A numerical value is given
to the extent of the lesions in each area: 1=<10%, 2=10-30%,
3=30-50%, 4=50-70%, 5=70-90%, and 6=90-100%. E,
I, and D were scored on a five-point scale (0=no symptoms,
1=slight, 2=moderate, 3=marked, and 4=very marked) to
obtain a final PASI score between 0 and 72. The PASI scores
of the patients who took part in this study ranged between
2.0 and 27.4. The patients with PASI scores <30 were enrolled
in this study in order to determine whether alterations in the
levels of SPT and ceramidase are closely correlated to the clin-
ical severity in psoriatic patients (Table 1). All patients with
PASI scores >30 were excluded in this study because their
skin lesions were shown to be transformed into severe vari-
ants of psoriasis, such as the erythrodermic type.
Western blot analysis
Every frozen skin sample was added to 400  L of Folch
solution (CHCl3: MeOH 2:1, v/v mixture) and was homoge-
nized using a polytron homogenizer, and 200  L of 0.1 M
KCl was added. The mixture was centrifuged at 3,000 rpm
for 5 min each. The upper phase containing the extracted
proteins was separated. This process was repeated one more
time. The protein concentration was determined by BCA pro-
tein assay (Pierce, Rockford, U.S.A.) according to the manu-
facturer’s protocol. Fifty micrograms of protein was fraction-
ated on 10% Sodium Dodecyl Sulfate Polyacrylamide Gel
Electrophoresis (SDS-PAGE) and transferred to a nitrocellu-
lose membrane by electrophoresis. The membranes were bloc-
ked with 5% non-fat dry milk for 1 hr at room temperature
and incubated with prepared human SPT, ceramidase, and
tubulin antibody (Labfrontier, Seoul, Korea) at a 1:250 dilu-
tion with Tris-buffered saline containing 0.05% Tween-20
(TSB-T) for 1 hr. After washing with TBS-T for 1 hr, the mem-
branes were reacted with horseradish peroxidase-conjugated
anti-rabbit IgG antibody (Amersham Biosciences, Bucking-
hamshire, U.K.) diluted 1:250 with TBS-T for 1 hr at room
temperature. After washing the membranes with TBS-T for
1 hr, the protein level was detected using the ECL chemilumi-
Patient 
No.
S/T in
non-lesion
S/T
in lesion
% 
Reduction
�
C/T in
non-lesion
C/T
in lesion
% Reduction
or increase
�
PASI 
score
1 8.26 3.02 36.5 0.530 0.861 162.4 9.8
2 8.81 3.01 34.2 0.376 0.662 176.0 6.0
3 9.24 3.00 32.4 0.105 0.181 172.3 15.6
4 6.89 2.00 29.0 0.249 0.183 73.4 10.4
5 4.63 3.36 72.5 0.193 0.317 164.2 8.0
6 9.17 4.67 50.9 0.059 0.049 83.0 4.2
7 7.13 3.63 50.9 0.440 0.507 115.2 2.0
8 8.23 2.19 26.5 0.110 0.259 235.4 27.4
9 8.98 3.00 33.4 0.869 1.006 115.7 16.8
10 4.29 2.42 56.3 0.370 0.299 80.8 3.8
11 9.97 5.59 56.1 0.545 1.070 196.3 3.0
12 7.19 1.26 17.5 0.350 0.689 139.7 20.6
13 5.35 2.11 39.5 1.556 0.625 40.1 8.4
14 6.32 3.33 52.7 0.556 0.249 44.7 6.8
15 7.93 2.02 25.4 0.142 0.121 85.2 18.4
16 8.55 4.16 48.7 0.044 0.036 81.8 5.8
17 6.56 3.08 47.0 0.212 0.028 13.2 8.8
18 7.65 2.25 29.4 0.023 0.025 108.6 18.2
19 6.70 3.13 46.7 0.179 0.131 73.1 5.6
20 5.87 3.37 57.4 0.243 0.194 79.8 14.6
21 9.70 2.58 26.5 0.396 0.660 166.6 14.8
22 8.83 3.38 38.3 0.148 0.081 54.7 13.6
23 5.21 4.56 87.6 0.386 0.240 62.1 4.8
24 8.49 4.24 49.9 0.322 0.411 127.6 4.6
Mean±SD 7.49±1.58* 3.14±0.99* 0.350±0.318 0.370±0.310
Table 1. SPT, ceramidase, and PASI score
*Significant difference of SPT/tubulin levels between the lesional epidermis and non-lesional epidermis (n=24, p<0.05). 
� The percent reduction was
calculated as (SPT/tubulin in lesion divided by SPT/tubulin in non-lesional level)×100 . 
�
The percent reduction or increase was calculated as (cerami-
dase/tubulin in lesion divided by ceramidase/tubulin in non-lesional level)×100. S, serine palmitoyltransferase; T, tubulin; C, ceramidase. 864 K-K. Hong, H.-R. Cho, W.-C. Ju, et al.
nescence kit (Amersham Bioscience, Buckinghamshire, U.K.).
Statistical analysis
The statistical significance of the difference in the levels of
SPT/tubulin and ceramidase/tubulin between the lesional and
the non-lesional samples of psoriasis patients was assessed
using a paired t-test. The correlations between the levels of
SPT and the PASI scores were determined using the Spear-
man correction test. p values less than 0.05 were considered
Fig. 1. Western blot analysis of SPT in the lesional and the non-lesional epidermis of posriasis patients. Western blotting was performed
using anti-SPT antibodies, as described in Materials and Method. The level of SPT expression was quantified by densitometry and is
expressed as ratio of SPT and tubulin. *, significant differences between lesional epidermis and non-lesional epidermis (p<0.05).
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Fig. 2. Western blot analysis of ceramidase in the lesional and the non-lesional epidermis of posriasis patients. Western blotting was per-
formed using anti-ceramide antibodies, as described in the Materials and Method. The level of ceramidase expression was quantified by
densitometry and is expressed as a ratio of ceramidase and tubulin. However, we could not find any statistically significant difference
between two groups.
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statistically significant. 
RESULTS
Protein expression of Serine palmitoyltransferase and
ceramidase in psoriatic epidermis and non-lesional
epidermis 
Western blot analysis of SPT and ceramidase in the lesional
and non-lesional epidermis of psoriasis patients is shown in
Fig. 1, 2. When the level of SPT protein expression was quan-
tified by densitometry and was expressed as a ratio of SPT to
tubulin (Fig. 1, 2), the levels of SPT expression in the lesion-
al epidermis was significantly lower (range, 1.26-5.59) than
those in the non-lesional epidermis ( range, 4.63-9.97) (Fig.
1). In contrast, levels of ceramidase expression in the lesion-
al epidermis ranged from 0.025 to 1.070, and those in the
non-lesional epidermis ranged from 0.023 to 1.556, which
indicates that there was no significant difference in the level
of ceramidase of lesional and non-lesional epidermis of psoria-
sis (Fig. 2). After normalization with tubulin, the mean level
of SPT/tubuin in the lesional epidermis was significantly de-
creased compared to the non-lesional epidermis as shown in
Fig. 3A (p<0.05). However, there was no significant difference
in the mean ratio of ceramidase to tubulin between lesional
psoriatic skin and non-lesional skin (Fig. 3B).
Correlation of SPT, ceramidase, and PASI score
The protein expression of SPT and ceramidase of non-lesion
and lesion, and the PASI score in psoriatic patients are shown
in Table 1. Although the absolute level of SPT varied from
patient to patient, SPT expression of lesional epidermis was
significantly less (p<0.05) than that of non-lesional epider-
mis, as with the percent reduction ranging from 17.5 to
87.6. When the PASI score was applied, there was a signifi-
cant negative correlation between percent reduction of SPT
expression in the lesional epidermis and the PASI score (r=
-0.76, p=0.01) as shown in Fig. 4. However, there was no
significant correlation between percent reduction of cerami-
dase expression in the lesional epidermis and the PASI score.
DISCUSSION
The epidermis contains a large amount of sphingolipids,
which are concentrated in upper, differentiated cell layer,
where they are thought to participate in the maintenance of
the cutaneous permeability barrier (11). Among the epider-
mal sphingolipids, ceramide is the main lipid in the stratum
corneum and its depletion is thought to be one of the etio-
logical factors for barrier disruption in skin conditions (1-4).
Moreover, as a signal transduction molecule, ceramide is in-
volved in the cell proliferation and apoptosis signaling path-
way via activation of several signal transduction molecules,
and its depletion is related with various skin disease such as
atopic dermatitis or psoriasis (5-8). Synthesis of ceramide is
regulated by several enzymes such as sphingomyelinase,  -
glucocerebrosidase, and ceramidase (12-15). Also a de novo
pathway mediated by SPT functions as a key pathway of
ceramide systhesis (16) (Fig. 5).
SPT is a key enzyme in sphingolipid biosynthesisis. It is
the first committed and rate-limiting step in sphigolipid
synthesis (17, 18). One of the substrates for SPT is various
Fig. 4. Correlation between the percentage reduction in the ration
of SPT/tubulin in the lesional epidermis and the PASI scores of
psoriasis patients. A significant negative correlation was observed
(Spearman’s rho=-0.76, p=0.01).
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Fig. 3. (A) The mean ratio of SPT and tubulin of the lesional epidermis was significantly decreased compared to that of the non-lesional
epidermis. *, significant differences between lesional epidermis and non-lesional epidermis (p<0.05). (B) However, there was no signifi-
cant difference between the mean ratio of ceramidase to tubulin in the lesional epidermis and that of the non-lesional epidermis.866 K-K. Hong, H.-R. Cho, W.-C. Ju, et al.
acyl-CoAs. In the mammalian cells, palmitoyl CoA is one of
the most abundant acly-CoA types and it is the predomi-
nant acyl-CoA substrate of SPT in vivo (19-21). However,
SPT strictly utilizes L-serine as its amino acid substate (22).
In human epidermis, SPT catalyzes the palmitoyl CoA and
L-serine to synthesize ceramide (17).
Ceramidase hydrolyzes ceramide into shpingophosphoryl-
choline and free fatty acid. It is demonstrated that marked
elevated activity of this enzyme is responsible for low levels
of cermaide in stratum corneum of atopic dermatitis patients
(23).
In our previous study, decreased ceramide in psoriatic skin
lesions is shown to be responsible for epidermal hyperplasia
via downregulation of proapoptotic signal cascade such as
PKC- and JNK. In contrast, DAG levels were elevated
and free fatty acid levels were not changed (8, 9). However,
in the past study, we could not elucidate what makes ceramide
decreased in psoriatic skin lesion.
In this study, we measured the expression of SPT and cera-
midase in both psoriatic epidermis and non-lesional epider-
mis. SPT is one of the enzymes, which is related to the syn-
thesis of ceramide, and ceramidase is a catalytic enzyme,
which is related to the decrease of the levels of ceramide.
The results of this experiment showed that levels of SPT
were significantly decreased in the psoriatic skin. However,
the levels of ceramidase showed no significant difference
between psoriatic epidermis and non-lesional epidermis. We
also evaluated the relationship between the PASI score and
decreased levels of SPT to determine the role of decreased
SPT on the severity of psoriasis. The correlation between the
percentage reduction in the ratio of SPT/tubulin in the lesional
epidermis and the PASI scores showed a significantly nega-
tive correlation. Considering above results, decreased levels
of ceramide in psoriatic skin, as shown in our previous study,
are responsible for decreased levels of SPT in psoriatic skin
lesion, and their levels of reduction are highly related to the
clinical severity of psoriasis. However, according to this ex-
periment, ceramidase does not seem to have a relation with
psoriatic epidermal changes, and this result is different from
that of the previous study on ceramidase activity in atopic
dermatitis (23). 
In conclusion, we demonstrated that the decreased levels
of ceramide in the psoriatic epidermis is related to its de novo
synthetic pathway, which is associated with levels of SPT, and
the levels of SPT are closely related to the clinical severity of
psoriasis. Considering that psoriasis is one of the inflamma-
tory skin diseases, several cytokines or growth factors secret-
ed by keratinocytes, Langerhans cells, or T-cells in the psori-
atic skin lesion seem to affect the expression of serine pal-
mitoyltransferase, and this postulation need further studies.
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